Skip to main content
All lobbying filings

Red+blue Strategies

Red+blue Strategies filed a Q1 report for Pharmaceutical Care Management Association (Pcma) on April 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Pharmaceutical Care Management Association (Pcma) · PCMA represents pharmacy benefit managers, who administer the nation's covered Rx benefits

As filed: RED+BLUE STRATEGIES for PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA).

All filings by Red+blue Strategies · Everything Pharmaceutical Care Management Association (Pcma) has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Issues related to pharmacy benefit managers and their role in public and private insurance coverage. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to pharmacy benefit managers.

 Bills named in this filing 1
  • H.R. 7148
    Consolidated Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem